![Wells Fargo Upgrades Fate Therapeutics On Induced Pluripotent Stem Cell Outlook]( "Wells Fargo Upgrades Fate Therapeutics On Induced Pluripotent Stem Cell Outlook")
Update from the annual meeting of the American Society of Hematology (ASH) suggested that initial data for Fate Therapeutics Inc’s (NASDAQ: FATE ) FT500 and FT516 therapies were well received by both clinicians ...
from Yahoo Finance https://ift.tt/36h4fxG
0 comments:
Post a Comment